National institut of Cardiology
Rio de Janeiro, 3600/100, Brazil
NCT Number: NCT01619436
The purpose of this study is the randomized blind research of the assessment of the different levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during cardiac surgery, the investigators would like to know if the glycemia levels in clondine group will be lower than placebo group.
Looking for future studies?
Notify Me45 year–80 year
All sexes
Interventional
Phase 4
Rio de Janeiro, 3600/100, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
bolus, clonidine 2 mg/kg IV
1 ML ringer lactato IV, as placebo
Time frame: 2 years
Clonidine 2 mg/kg IV. assessment sedation with Ransay scale
Time frame: 2 years
clonide 2 mg/kg. assessment the glycemia during CPB.
Federal University of Juiz de Fora
Other
The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.